Search for Clinical Trial Results

Sponsored By

Arthritis, Psoriatic - 35 Studies Found

Status Study
Completed Study Name: Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Date: 2015-03-16
Interventions: Biological: Secukinumab Anti IL-17a monoclonal antibody
Completed Study Name: Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Date: 2014-05-15
Interventions:
  • Drug: UCB4940 40 mg

Completed Study Name: Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment (WPAI))
Condition: Psoriatic Arthritis
Date: 2015-01-30
Completed Study Name: Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy
Condition: Arthritis, Psoriatic, Psoriasis
Date: 2006-03-14
Completed Study Name: A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation
Condition: Psoriatic Arthritis
Date: 2016-06-21
Interventions:
  • Biological: adalimumab
  • Drug: methotrexate

Completed Study Name: TIght COntrol of Psoriatic Arthritis
Condition: Psoriatic Arthritis
Date: 2010-04-15
Interventions:
  • Drug: Intensive management or Tight control

Active, not recruiting Study Name: PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Date: 2010-09-29
Interventions:
  • Drug: Apremilast 20mg Apremila
Completed Study Name: Effect of Secukinumab in the Treatment of Psoriatic Arthritis
Condition: Psoriatic Arthritis
Date: 2016-07-20
Interventions: Drug: Secukinumab All eligible patients registered into the study will receive four 150 - 300 mg subcuta
Terminated Study Name: A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197
Condition: Psoriatic Arthritis
Date: 2015-04-24
Interventions: Drug: ABT-122 Injection
Completed Study Name: A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate
Condition: Psoriatic Arthritis
Date: 2015-01-23
Interventions:
  • Biological: adalimumab Double-
<<< Previous | Next >>>